Nurses, Patients Prefer Biosimilar Adalimumab's Autoinjector, Survey Finds - The Center for Biosimilars

Nurses, Patients Prefer Biosimilar Adalimumab's Autoinjector, Survey Finds  The Center for Biosimilars

A recent study aimed to evaluate patients' and nurses' preferences for the autoinjector for a biosimilar adalimumab marketed as Imraldi in the European Union ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases